Analysis of the interferon-γ-induced secretome of intestinal endothelial cells: putative impact on epithelial barrier dysfunction in IBD

Front Cell Dev Biol. 2023 Aug 14:11:1213383. doi: 10.3389/fcell.2023.1213383. eCollection 2023.

Abstract

The development of inflammatory bowel diseases (IBD) involves the breakdown of two barriers: the epithelial barrier and the gut-vascular barrier (GVB). The destabilization of each barrier can promote initiation and progression of the disease. Interestingly, first evidence is available that both barriers are communicating through secreted factors that may accordingly serve as targets for therapeutic modulation of barrier functions. Interferon (IFN)-γ is among the major pathogenesis factors in IBD and can severely impair both barriers. In order to identify factors transmitting signals from the GVB to the epithelial cell barrier, we analyzed the secretome of IFN-γ-treated human intestinal endothelial cells (HIEC). To this goal, HIEC were isolated in high purity from normal colon tissues. HIEC were either untreated or stimulated with IFN-γ (10 U/mL). After 48 h, conditioned media (CM) were harvested and subjected to comparative hyper reaction monitoring mass spectrometry (HRM™ MS). In total, 1,084 human proteins were detected in the HIEC-CM. Among these, 43 proteins were present in significantly different concentrations between the CM of IFN-γ- and control-stimulated HIEC. Several of these proteins were also differentially expressed in various murine colitis models as compared to healthy animals supporting the relevance of these proteins secreted by inflammatory activated HIEC in the inter-barrier communication in IBD. The angiocrine pathogenic impact of these differentially secreted HIEC proteins on the epithelial cell barrier and their perspectives as targets to treat IBD by modulation of trans-barrier communication is discussed in detail.

Keywords: IBD-inflammatory bowel disease; angiocrine; barrier; cytokines; endothelial; interferon; paracrine; secretion.

Grants and funding

This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Project-ID 375876048—TRR 241 subproject A03 to CB and A06 to NB-L and MS, Project-ID 429280966—TRR 305 subproject B07 to NB-L and B08 to EN, Project-ID 437201724—STU 238/10-1 to MS, Project-ID 280163318—FOR 2438-2 to EN and MS, Project-ID 292410854—BR 5196/2-1 to NB-L; by the W. Lutz Stiftung, the Forschungsstiftung Medizin am Universitätsklinikum Erlangen and a start-up funding from the TRR 241 to NB-L and MS.